Cordis US Corp. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   REALPASS · Post-Approval Study of PALMAZ MULLINS XD™ in…REALPASS · Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis

   Enrollment reduced: 75 → 35 participants

   Also in this update: Recruitment opened; Primary and study completion pushed from Dec 2027 to Jun 2028

   Cordis US Corp.·Not specified· NCT07122518· Registry history of NCT07122518 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.